Özcan, M. Et Al. 2020. A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm. ASCO 2020 .

Özcan, M., Koyun, D., Cengiz Seval, G., Uslu, A., Kırcali, E., Öztürk, C., ... Civriz Bozdağ, S.(2020). A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm . ASCO 2020

Özcan, MUHİT Et Al. "A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm," ASCO 2020, 2020

Özcan, MUHİT Et Al. "A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm." ASCO 2020 , 2020

Özcan, M. Et Al. (2020) . "A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm." ASCO 2020 .

@conferencepaper{conferencepaper, author={MUHİT ÖZCAN Et Al. }, title={A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm}, congress name={ASCO 2020}, city={}, country={}, year={2020}}